Sinovac Biotech (SVA) Total Non-Current Liabilities (2009 - 2026)
Sinovac Biotech (SVA) posted Total Non-Current Liabilities of $582.73 million for Q2 2026, down 9.3% from $642.18 million a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Sinovac Biotech's Total Non-Current Liabilities came in at $605.11 million, up 2.2% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 42.9% (FY2020 to FY2025).
- In prior years, Sinovac Biotech's Total Non-Current Liabilities was $591.95 million in FY2024 (-12.5%), $676.83 million in FY2023 (+27.5%), $530.85 million in FY2022 (-22.7%) and $686.96 million in FY2021 (+576.2%).
- The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q2 2024.
- On a year-over-year basis, Total Non-Current Liabilities increased in two of the last four quarters, with growth averaging 0.1%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2021, with growth of 576.2%; the weakest was Q2 2023, with a decline of 26.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 582.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 582.73 Mn |
| Dec 31, 2025 | 605.11 Mn |
| Jun 30, 2025 | 642.18 Mn |
| Dec 31, 2024 | 591.95 Mn |
| Jun 30, 2024 | 535.96 Mn |
| Dec 31, 2023 | 676.83 Mn |
| Jun 30, 2023 | 298.13 Mn |
| Dec 31, 2022 | 530.85 Mn |
| Jun 30, 2022 | 407.07 Mn |
| Dec 31, 2021 | 686.96 Mn |
| Jun 30, 2021 | 189.91 Mn |
| Dec 31, 2020 | 101.59 Mn |
| Sep 30, 2020 | 87.45 Mn |
| Jun 30, 2020 | 77.87 Mn |
| Mar 31, 2020 | 12.54 Mn |
| Dec 31, 2019 | 12.91 Mn |
| Sep 30, 2019 | 22.72 Mn |
| Jun 30, 2019 | 22.22 Mn |
| Mar 31, 2019 | 25.01 Mn |
| Dec 31, 2018 | 19.65 Mn |
API Access
Sinovac Biotech Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();